The phylodynamics of SARS-CoV-2 during 2020 in Finland | Communications Medicine
By Tarja Sironen, Hannimari Kallio-kokko & Eliisa Kekäläinen
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
By Bridget L Menasche, Zhenhao Fang & Albert Ko
Metagenomic pipeline for identifying co-infections among distinct SARS-CoV-2 variants of concern: study cases from ...
By Melany Calderon-osorno
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
By Leon Bergfeld, Marietta Jank & Lutz Naehrlich
Inactivated whole-virion vaccine BBV152/Covaxin elicits robust cellular immune memory to SARS-CoV-2 and variants ...
By Alba Grifoni, Alessandro Sette & Nimesh Gupta
Low-dose self-amplifying mRNA COVID-19 vaccine drives strong protective immunity in non-human primates against ...
By Karin Jooss, Leonid Gitlin & Anne Van Abbema